Home

Remus Pharmaceuticals Ltd 52 Week Low

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

YEARLOW

₹ 1591.25

Last updated on: May 02, 2025

Key Highlights

  • The 52 Week Low of Remus Pharmaceuticals Ltd is ₹ 1591 as of 02 May 25 .

Company Fundamentals for Remus Pharmaceuticals Ltd

Market Price of Remus Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 May 20251981
30 Apr 20252020.4
29 Apr 20252078.1
28 Apr 20252025.1
25 Apr 20251903.6
24 Apr 20251956.35
23 Apr 20251997.1
22 Apr 20251995
21 Apr 20252036.55
17 Apr 20252004

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Remus Pharmaceuticals Ltd News Hub

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be hel

Read more

31 Aug 24

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9

Read more

09 Nov 24

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 202

Read more

07 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Remus Pharmaceuticals Ltd

Why is it important to track the 52-week low of Remus Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Remus Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Remus Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Remus Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Remus Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Remus Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Remus Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Remus Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Remus Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Remus Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Remus Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Remus Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Remus Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions